Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2022/02/040450
CTRI/2022/02/040450
Not yet recruiting
Phase 2

To Observe the Safety and Efficacy of Intradermal Injection of Tranexamic Acid in Patients of Melasma

Dr Meghna Khatri0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: L811- Chloasma

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: L811- Chloasma
Sponsor
Dr Meghna Khatri
Status
Not yet recruiting
Last Updated
4 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
Dr Meghna Khatri

Eligibility Criteria

Inclusion Criteria

  • •1\. Patients willing to participate in the study.
  • •2\. Patients of either sex with clinical features of melasma.
  • •3\. Patients in the age group of 18\-60 years.

Exclusion Criteria

  • •1\.Patients below the age of 18 years and above the age of 60 years.
  • •2\.Patients having any other hyperpigmented disorder on the face.
  • •3\.Patients not willing to participate in the study.
  • •4\.Pregnant or lactating females.
  • •5\.Patients with bleeding disorders.
  • •6\.Patients on anticoagulant therapy.
  • •7\.Patients having hypersensitivity to tranexamic acid.
  • •8\.Patients having bilaterally asymmetrical pigmentation.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 1
Investigating nanofat injection and conditioned medium derived from stem cells in the treatment of androgenic alopeciaHair loss.Nonscarring hair loss, unspecifiedL65.9
IRCT20200127046282N34Tehran University of Medical Sciences10
Not yet recruiting
Phase 1
Investigating the safety and efficacy of injection of fat tissue cells in patients with sclerodermascleroderma.Systemic sclerosis [scleroderma]
IRCT20200127046282N35Tehran University of Medical Sciences18
Not yet recruiting
Not Applicable
Comparative study of Intradermal versus Intralesional Purified Protein Derivative (PPD) for treatment of common warts in childreHealth Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
CTRI/2019/07/020070Himachal Pradesh University
Not yet recruiting
Phase 1
Assessment of the effect of exosomes in the treatment of melasma
IRCT20221130056672N6Tehran University of Medical Sciences30
Completed
Not Applicable
To evaluate the efficacy and safety of subcutaneous and intravenous abatacept.Rheumatoid arthritis
JPRN-UMIN000013440Osaka Medical College50